Zixiao Li, PhD, MD., male, born in 11-13-1978 in China, is the Director of Center for Healthcare Quality and Research, China National Clinical Research Center for Neurological Diseases, Office Director of National Center for Healthcare Quality Management in Neurological Diseases, and Vice Director of Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, in 2018.
He received his PhD and M.D. of Neurology from the Capital Medical University and did his research fellow of stroke care quality and outcome research in Massachusetts General Hospital mentored by Drs. Aneesh B. Singhal and Lee H. Schwamm from 01/2017 to 12/2017 and Duke Clinical Research Institute mentored by Profs. Ying Xian, Janet Prvu Bettger, and Eric Peterson from 12/2014 to 02/2015.
His research focuses on stroke care delivery quality assessment, implementation and improvement in China. He assisted to establish a nationwide network for stroke care quality including 2494 secondary and tertiary hospitals in China and develop a web-based patient management tool to collect the stroke care delivery data from this nationwide network. Until now, over 1.4 million patients with acute stroke or TIA were collected and given the intervention tools of stroke care including clinical pathway and standard of operations for key performance measures, such as IV t-PA and anticoagulant for atrial fibrillation. He developed a multifaceted quality improvement intervention for stroke care, designed and conducted a cluster-randomized clinical trial to identify that this multifaceted quality improvement intervention can improve hospital personnel adherence to evidence-based performance measures in patients with acute ischemic stroke and decrease 1-year new vascular events. This finding was published in JAMA in 2018 (doi:10.1001/JAMA.2018.8802).
He is the primary investigator of Big data and biological bank platform of cerebrovascular disease (Ministry of Science and Technology and the Ministry of Health of the People’s Republic of China, National S & T Major Project of China: 2017YFC1310900, 2.4 million dollars) from 11/2017 to 12/2020. He is in charge of the collaborative project of China Stroke Association and American Heart Association/American Stroke Association: Improve Stroke Care in China. Drs. Yongjun Wang (Dean of Beijing Tiantan Hospital, and executive chief of China Stroke Association) and Lee Schwamm are co-PIs of this project focusing on the improvement of acute reperfusion treatment for stroke patients in China.
He was awarded by American Heart Association with Early Career Investigator Travel Stipend, Quality of Care and Outcomes Research 2016 conference. He was invited to take oral presentations to introduce stroke care quality research in International Stroke Conference and published over 25 publications about stroke care and outcome research in China.
Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.
With support from:
*All WSO educational programs are independently developed and delivered.